Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: The MrOS study

Urology

Volumn 68, Issue 4, 2006, Pages 804-809

  Taylor, Brent C ^a   Wilt, Timothy J ^a,b   Fink, Howard A ^a,b   Lambert, Lori C ^c   Marshall, Lynn M ^c   Hoffman, Andrew R ^d   Beer, Tomasz M ^c   Bauer, Douglas C ^e   Zmuda, Joseph M ^f   Orwoll, Eric S ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; AGED; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DAILY LIFE ACTIVITY; DISEASE CLASSIFICATION; DISEASE SEVERITY; HEALTH CARE QUALITY; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; SELF CONCEPT; UNITED STATES; URETHRA DISEASE; URINARY TRACT DISEASE;

ACTIVITIES OF DAILY LIVING; AGE FACTORS; AGED; AGED, 80 AND OVER; COHORT STUDIES; CROSS-SECTIONAL STUDIES; HUMANS; MALE; PREVALENCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SEX FACTORS; UNITED STATES; URINATION DISORDERS;

EID: 33750375107     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2006.04.019     Document Type: Article

References (26)

1. Chute C.G., Panser L.A., Girman C.J., et al. The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol 150 (1993) 85-89
2. Andersson S.O., Rashidkhani B., Karlberg L., et al. Prevalence of lower urinary tract symptoms in men aged 45-79 years: a population-based study of 40,000 Swedish men. BJU Int 94 (2004) 327-331
3. Boyle P., Robertson C., Mazzetta C., et al. The relationship between lower urinary tract symptoms and health status: the UREPIK study. BJU Int 92 (2003) 575-580
4. Donovan J.L., Kay H.E., Peters T.J., et al., International Continence Society-Benign Prostatic Hyperplasia. Using the ICSOoL to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS-"BPH" Study. Br J Urol 80 (1997) 712-721
5. Girman C.J., Jacobsen S.J., Tsukamoto T., et al. Health-related quality of life associated with lower urinary tract symptoms in four countries. Urology 51 (1998) 428-436
6. Hunter D.J., McKee M., Black N.A., et al. Health status and quality of life of British men with lower urinary tract symptoms: results from the SF-36. Urology 45 (1995) 962-971
7. Mozes B., Maor Y., and Shmueli A. The competing effects of disease states on quality of life of the elderly: the case of urinary symptoms in men. Qual Life Res 8 (1999) 93-99
8. Roberts R.O., Jacobsen S.J., Rhodes T., et al. Natural history of prostatism: impaired health states in men with lower urinary tract symptoms. J Urol 157 (1997) 1711-1717
9. Welch G., Weinger K., and Barry M.J. Quality-of-life impact of lower urinary tract symptom severity: results from the Health Professionals Follow-up Study. Urology 59 (2002) 245-250
10. Orwoll E., Blank J.B., Barrett-Connor E., et al. Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study-a large observational study of the determinants of fracture in older men. Contemp Clin Trials 26 (2005) 569-585
11. Blank J.B., Cawthon P.M., Carrion-Petersen M.L., et al. Overview of recruitment for the osteoporotic fractures in men study (MrOS). Contemp Clin Trials 26 (2005) 557-568
12. Barry M.J., Fowler Jr. F.J., O'Leary M.P., et al., Measurement Committee of the American Urological Association. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol 148 (1992) 1549-1557
13. Barry M.J., Fowler Jr. F.J., O'Leary M.P., et al., Measurement Committee of the American Urological Association. Correlation of the American Urological Association symptom index with self-administered versions of the Madsen-Iversen, Boyarsky and Maine Medical Assessment Program symptom indexes. J Urol 148 (1992) 1558-1563
14. O'Leary M.P., Barry M.J., and Fowler Jr. F.J. Hard measures of subjective outcomes: validating symptom indexes in urology. J Urol 148 (1992) 1546-1548
15. Ware J.E., Kosinski M., and Keller S.D. SF-12: How to Score the SF-12 Physical and Mental Health Summary Scores. 3rd ed (1998), The Health Institute, Lincoln, RI
16. Washburn R.A., Smith K.W., Jette A.M., et al. The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol 46 (1993) 153-162
17. Ensrud K.E., Fullman R.L., Barrett-Connor E., et al. Voluntary weight reduction in older men increases hip bone loss: the osteoporotic fractures in men study. J Clin Endocrinol Metab 90 (2005) 1998-2004
18. Spiegelman D., and Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol 162 (2005) 199-200
19. Garraway W.M., Russell E.B., Lee R.J., et al. Impact of previously unrecognized benign prostatic hyperplasia on the daily activities of middle-aged and elderly men. Br J Gen Pract 43 (1993) 318-321
20. Homma Y., Kawabe K., Tsukamoto T., et al. Epidemiologic survey of lower urinary tract symptoms in Asia and Australia using the international prostate symptom score. Int J Urol 4 (1997) 40-46
21. Hunter D.J., Berra-Unamuno A., and Martin-Gordo A. Prevalence of urinary symptoms and other urological conditions in Spanish men 50 years old or older. J Urol 155 (1996) 1965-1970
22. Roberts R.O., Rhodes T., Panser L.A., et al. Natural history of prostatism: worry and embarrassment from urinary symptoms and health care-seeking behavior. Urology 43 (1994) 621-628
23. Boyle P., Robertson C., Mazzetta C., et al. The prevalence of lower urinary tract symptoms in men and women in four centres: the UrEpik study. BJU Int 92 (2003) 409-414
24. AUA Guideline on Management of Benign Prostatic Hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. J Urol 170 2 Pt 1 (2003) 530-547
25. Saigal C.S., and Joyce G. Economic costs of benign prostatic hyperplasia in the private sector. J Urol 173 (2005) 1309-1313
26. Wei J.T., Calhoun E., and Jacobsen S.J. Urologic diseases in America project: benign prostatic hyperplasia. J Urol 173 (2005) 1256-1261